Mostrar el registro sencillo del ítem

dc.contributor.authorFernández Landa, Julen
dc.contributor.authorFernández Lázaro, Diego 
dc.contributor.authorCalleja González, Julio
dc.contributor.authorCaballero García, Alberto 
dc.contributor.authorCórdova Martínez, Alfredo 
dc.contributor.authorLeón Guereño, Patxi
dc.contributor.authorMielgo Ayuso, Juan Francisco 
dc.date.accessioned2022-03-24T10:52:59Z
dc.date.available2022-03-24T10:52:59Z
dc.date.issued2020
dc.identifier.citationBiomolecules, 2020, vol. 10, n. 1, 140es
dc.identifier.issn2218-273Xes
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/52632
dc.descriptionProducción Científicaes
dc.description.abstractCreatine monohydrate (CrM) and β-hydroxy β-methylbutyrate (HMB) are widely studied ergogenic aids. However, both supplements are usually studied in an isolated manner. The few studies that have investigated the effect of combining both supplements on exercise-induced muscle damage (EIMD) and hormone status have reported controversial results. Therefore, the main purpose of this study was to determine the effect and degree of potentiation of 10 weeks of CrM plus HMB supplementation on EIMD and anabolic/catabolic hormones. This study was a double-blind, placebo-controlled trial where participants (n = 28) were randomized into four different groups: placebo group (PLG; n = 7), CrM group (CrMG; 0.04 g/kg/day of CrM; n = 7), HMB group (HMBG; 3 g/day of HMB; n = 7), and CrM-HMB group (CrM-HMBG; 0.04 g/kg/day of CrM plus 3 g/day of HMB; n = 7). Before (baseline, T1) and after 10 weeks of supplementation (T2), blood samples were collected from all rowers. There were no significant differences in the EIMD markers (aspartate aminotransferase, lactate dehydrogenase, and creatine kinase) among groups. However, we observed significant differences in CrM-HMBG with respect to PLG, CrMG, and HMBG on testosterone (p = 0.006; η2p = 0.454) and the testosterone/cortisol ratio (T/C; p = 0.032; η2p = 0.349). Moreover, we found a synergistic effect of combined supplementation on testosterone (CrM-HMBG = −63.85% vs. CrMG + HMBG = −37.89%) and T/C (CrM-HMBG = 680% vs. CrMG + HMBG = 57.68%) and an antagonistic effect on cortisol (CrM-HMBG = 131.55% vs. CrMG + HMBG = 389.99%). In summary, the combination of CrM plus HMB showed an increase in testosterone and T/C compared with the other groups after 10 weeks of supplementation. Moreover, this combination presented a synergistic effect on testosterone and T/C and an antagonistic effect on cortisol compared with the sum of individual or isolated supplementation.es
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherMDPIes
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.classificationMuscle damagees
dc.subject.classificationDaño musculares
dc.subject.classificationLactate dehydrogenasees
dc.subject.classificationLactato deshidrogenasaes
dc.subject.classificationCreatine kinasees
dc.subject.classificationCreatina quinasaes
dc.subject.classificationTestosteronees
dc.subject.classificationTestosteronaes
dc.titleLong-term effect of combination of creatine monohydrate plus β-Hydroxy β-Methylbutyrate (HMB) on exercise-induced muscle damage and anabolic/catabolic hormones in elite male endurance athleteses
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.holder© 2020 The Authorses
dc.identifier.doi10.3390/biom10010140es
dc.relation.publisherversionhttps://www.mdpi.com/2218-273X/10/1/140es
dc.peerreviewedSIes
dc.rightsAtribución 4.0 Internacional*
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem